Patient and public involvement in systematic reviews by Pollock, Alex et al.
Patient and public involvement in systematic reviews
Pollock, Alex; Campbell, Pauline; Synnot, Anneliese; Smith, Maureen; Morley, Richard
Published in:




Publisher's PDF, also known as Version of record
Link to publication in ResearchOnline
Citation for published version (Harvard):
Pollock, A, Campbell, P, Synnot, A, Smith, M & Morley, R 2021, Patient and public involvement in systematic
reviews. in GIN Public Toolkit: Patient and Public Involvement in Guidelines. Guidelines International Network
(GIN).
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please view our takedown policy at https://edshare.gcu.ac.uk/id/eprint/5179 for details
of how to contact us.
Download date: 02. Jan. 2022
 
Patient and public involvement in systematic reviews     Page 1 of 29 
© Copyright GIN 2021 
Patient and public involvement in systematic 
reviews 
Authors: Alex Pollock, Pauline Campbell, Anneliese Synnot, Maureen Smith, Richard 
Morley 
Corresponding author: alex.pollock@gcu.ac.uk 
Key messages of this chapter 
• Patient and public involvement (PPI) is important to ensure that systematic 
reviews are relevant and meaningful to people affected by a health condition and 
people using systematic reviews to inform health policy or practice. 
• There is no set formula or single method of involving people in a systematic 
review, nor is there evidence that any one way of involving people in a review is 
any more or less impactful.   
• Several different factors will influence the decision on the best approach for a 
specific systematic review, including (but not limited to) the aim of involvement, 
the people who are being involved, and the resources and time available for this. 
• PPI may be useful at any (or all) stages of a systematic review. 
• There should always be a clear aim associated with involvement of people within 
a systematic review. Often this aim will relate to decisions that need to be made 
within the systematic review process. Depending on the aim of involvement, 
people may be involved at 1 stage, at 2 or more stages, or they can be involved 
throughout the whole review. 
• Involvement of people in a systematic review can be considered as a continuum, 
from more involvement and control, to less involvement and control. But there is 
no evidence of a hierarchical association between level, impact, benefit or 
success of involvement.   
• Different levels and methods of involvement may be useful at different stages in a 
systematic review.   
• PPI in a systematic review should be clearly reported. 
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Terminology: systematic review 
A systematic review is a type of research method that brings together evidence, 
generally from research studies, to answer a pre-defined research question. 
Top Tips  
• Plan PPI in a systematic review prior to working on the review protocol. This is 
because involving patients and the public in the protocol is a good way of making 
sure your final review addresses what is important to people with lived experience 
of a health condition. 
• Planning should consider the project budget and payment of people’s time or 
expenses, provision of training, and whether ethical approval is required. You 
should consider the availability of these resources when deciding who you can 
involve and how. 
• Have a clear aim for involvement of patients and the public, and decide in 
advance what level of control that those involved will have over decision making 
within the review. Make sure that you communicate this clearly at the outset of the 
review. 
• Good communication is a key to success when involving people in systematic 
reviews. This means it must be timely, use clear language, and use a method that 
suits the people involved.  
• People can be involved at any (or all) stages in a review. When people are 
involved will depend on the aim of involvement. Involve people at: 
− the initial stages of the review (that is, protocol), to form the review question 
and scope 
− during the review, to contribute to searching, study selection, and collecting and 
analysing data 
− the final stages of the review, to support interpretation of the findings and 
dissemination of the review. 
• Who you involve, and when and how you involve them, should be decided taking 
into account the topic of the review, the resources available, and the experience of 
the review team.  
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• Have a conversation as early as possible with everyone involved about any 
resources they need, including financial payment for their time.  
• For systematic reviews that are being planned and conducted as part of a 
guideline development, a top and tail approach could potentially fit efficiently 
within the guideline process. 
• Adopting a formal research method or process can be useful when there is a 
clearly identified role, or aim, for the people involved.   
• The ACTIVE framework and the GRIPP2 (Guidance for Reporting Involvement of 
Patients and the Public 2) checklist (Staniskewsa et al. 2017) can be helpful for 
describing the planned involvement and reporting the actual involvement. 
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Aims of this chapter  
This chapter aims to: 
• highlight the importance of planning patient and public involvement (PPI) in a 
systematic review 
• describe who you might involve in your review 
• describe the stages when you might involve people 
• describe the different levels of involvement you might have 
• describe how people can be involved in a systematic review 
• provide a framework for describing and reporting how you involved people 
• signpost readers to a range of resources for further information. 
Planning involvement in a systematic review 
PPI and protocol development 
A key stage in any systematic review is writing a detailed systematic review protocol. 
The protocol lays out details of the scope and design of the review, and the methods 
that will be used to conduct the review. Preferably, a systematic review protocol will 
be made freely available before the start of the systematic review. This lets people 
know what you are planning and helps avoid duplication of effort (that is, someone 
else carrying out the same, or very similar, systematic review).    
Ideally, there will be PPI at the protocol development stage for the systematic review. 
It is good practice to have PPI contributors as core members of the review team. 
They play a key role in helping to plan how to involve additional PPI contributors 
throughout the review process. 
The systematic review protocol should describe the planned PPI. In particular, the 
protocol should give details of: 
• who will be involved, and how these people will be found or recruited 
• when (at what stages) within the review process people will be involved, with a 
clear aim of the involvement at these stages 
• how these people will be involved in order to meet the stated aim(s). 
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It is important to consider the key principles for good practice in involving people at 
the planning stage. The following issues are central to PPI in any research activity, 
including a systematic review: 
• supportive and positive relationships 
• clear and timely communication 
• the roles and expectations of everyone involved, which should be discussed and 
agreed in advance of any involvement 
• skills, knowledge and training (of researchers as well as of the people they 
involve) needed 
• clarity regarding time commitments and requirements.  
The project budget and payment for people’s time or expenses, provision of training, 
and whether ethical approval is required must also be considered. The availability of 
these resources will influence who you can involve and how.  
The Cochrane Consumer Network has published a Statement of Principles for 
Consumer Involvement in Cochrane to guide PPI. It highlights the importance of 
equity, inclusion and partnership. Communication and organisation are central to 
successful PPI, and it is important for researchers to consider practical points, such 
as accessibility (of meetings and materials) and having a clear point of contact for 
the people who are involved.   
Choosing who, when and how for your review 
There is no set formula or single method of involving people in a systematic review. 
Factors that will influence decisions around the best method for a specific systematic 
review include the: 
• Topic of the review, and the people who may be affected by the results of the 
review. 
• Aims of involving people. There may be a very specific aim to be met by involving 
people, such as informing the review outcomes, or supporting the dissemination of 
review results. 
• Time available to do the review. 
• Money available to support the review and involvement of people in the review. 
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• Expertise of researchers, and their experience of involving people in research. 
• Preferences of the individuals involved. 
• Desire for review findings to be locally, nationally or internationally generalisable. 
A review may focus on a topic of national importance, and consequently the 
methods of involvement could focus on gaining involvement across that individual 
nation. Alternatively, a review may be internationally relevant, so it may be 
appropriate to gain international views and opinions. 
Although the research team commonly makes the decisions on the plan, there will 
ideally be PPI in reaching the plan for the methods of involvement in the review. It is 
essential to consider the views and perspectives of the individual people who get 
involved, and to be prepared to be flexible and adaptive to the needs and 
suggestions of the people involved. For example, although you may have pre-
planned 1 large workshop to reach decisions on outcomes important to a review, this 
format may not be accessible to some people and you may need to adapt your 
plans. If you are asking people to read or comment on written documents it is 
important to find out whether any of the people involved have specific requirements 
to facilitate accessibility, such as larger font sizes or audio versions. When seeking 
people to get involved, you may consider circulating requests for involvement in a 
variety of formats to promote accessibility. For example, you could circulate an audio 
description alongside a written description of the project. Being flexible and 
responsive, and working in partnership with the people who get involved is important 
to ensure equity and inclusivity. 
One review can use a variety of different methods, each of which have a different 
approach to involvement, with different role classifications, and different levels of 
involvement. The following sections discuss key things to think about when planning 
PPI in your systematic review. 
Who to involve in a systematic review 
It is important to consider who the stakeholders for your systematic review are, and 
to involve representatives of key groups of people. Key groups to consider include: 
• patients and their family members 
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• carers 
• healthcare professionals 
• health policy makers 
• health funders 
• decision makers working in the relevant field.  
For a systematic review being conducted as part of a guideline development, the 
stakeholders for the review may be identical to the stakeholders for the guidelines. 
However, there may also be some differences. For example, if a systematic review is 
focused on a specific intervention or a population of people with a particular 
impairment or activity limitation, then it may be important to consider involving people 
with relevant specific lived experience.  
The 7Ps framework (Concannon et al. 2012), shown in table 1, can be a useful 
framework for identifying who to involve. Although it has been developed for a US 
situation, and for involving people in identifying and prioritising outcomes for 
research on an intervention’s effectiveness, the principles can be applied in other 
parts of the world, and in other types of research. 
Table 1 The 7Ps Framework to help identify who to involve in health research 
(Concannon et al. 2012 edited) 
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Category Description 
Patients and the public Current and potential consumers of patient-centred 
healthcare and population-focused public health, their 
caregivers, families, and patient and consumer advocacy 
organisations 
Providers  Individuals (for example, nurses, physicians, mental health 
counsellors, pharmacists, and other providers of care and 
support services) and organisations (for example, 
hospitals, clinics, community health centres, community-
based organisations, pharmacies, emergency medical 
services agencies, skilled nursing facilities, schools) that 
provide care to patients and populations 
Purchasers Employers, the self-insured, government and other entities 
responsible for underwriting the costs of healthcare 
Payers Insurers, Medicare and Medicaid, state insurance 
exchanges, individuals with deductibles, and others 
responsible for reimbursement for interventions and 
episodes of care 
Policy makers The White House, Department of Health and Human 
Services, Congress, states, professional associations, 
intermediaries, and other policy-making entities 
Product makers Drug and device manufacturers 
Principal investigators Other researchers and their funders 
 
In deciding who to involve it is important to consider the aim of the PPI and, 
therefore, the range of perspectives that are needed to meet that aim. For example, 
if the aim is to have general oversight of the review conduct, then perhaps, people 
with a general perspective need to be involved. But if the aim is to identify the 
outcomes of greatest importance to people with lived experience of a particular 
health condition, then it will be essential to involve people with relevant lived 
experience. Often, for PPI, what is of greatest importance is that the people involved 
have a lived experience of a particular health condition. Generally, knowledge or 
familiarity with research methods and technical terms is not a requirement for 
involvement. It is good practice to write a role specification that describes, in plain 
language, the experience or attributes that people you involve should have. Also 
consider the potential benefits for people who volunteer to get involved in a 
systematic review, and make these clear. For example, these could include 
payment, authorship, acknowledgement, training, or impacting on an area of 
research that is important to them. The National Institute for Health Research (NIHR) 
webpage on people in research has examples of descriptions of people sought to 
involve in health research. 
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How to recruit people 
After identifying the key groups of people to involve, strategies are required to find 
relevant individuals to approach and invite to get involved. The chapter on how to 
recruit and support patients and the public, and overcome barriers to their 
involvement in guideline development highlights different ways of identifying and 
reaching out to patient and public groups. Two broad strategies commonly used to 
find people to be involved in systematic reviews are: 
• An open recruitment strategy, in which opportunities for involvement are 
advertised to the general population, and anyone can volunteer to get involved 
(for example, advertising on the NIHR’s People in research webpage). Open 
strategies can be: 
− Fixed: After a group has been formed, advertising ceases and no new 
members are added. 
− Flexible: Advertising for new members is ongoing and group membership can 
fluctuate. This may mean that a series of workshops has different group 
members, or some group members may attend more than once. 
• A closed, or targeted, strategy, in which individual people, or individual groups, 
are invited to be involved. There are several strategies for recruiting a targeted 
group: 
− Invitation: People known by name (or reputation) to the researchers will be 
invited to get involved. This can also be described as ‘nomination’. 
− Existing groups: Rather than recruiting specific named individuals, the 
membership of an existing group is invited to get involved. Because different 
groups vary in how they operate, this can impact on the membership. In some 
cases, a group may have closed membership (that is, the same individuals 
make up the group), and sometimes a group may have open membership (that 
is, the group membership changes over time). 
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− Purposive sampling: A qualitative research framework is used for recruitment, 
generally aimed at getting representation of people with key pre-determined 
characteristics, experience or expertise. Although this results in a ‘targeted’ 
group, with closed membership, the strategies for identifying the population 
from which to sample can be similar to those for open involvement (that is, 
advertising). 
How many people to involve 
How many people you involve in your systematic review will depend on several 
factors. A key factor is the aim of PPI and, linked to the aim, how you are going to 
involve people (see the section on how to involve people in a systematic review). 
The factors listed in the section on choosing who, when and how for your review will 
also influence decisions about how many people to involve. The numbers to involve 
will also depend on the different groups of people that you want to have represented 
(see the section on who to involve in a systematic review). Work in partnership with 
the people you involve to ensure that they are comfortable with the number and 
range of people involved. When small numbers of people are involved, for example, 
as members of a steering or advisory group, ask them if they feel they can represent 
the different viewpoints, or whether additional input is required.  
In an exploration of PPI in a range of systematic reviews, Pollock et al. (2018) found 
that for: 
• face-to-face meetings, the number of people involved ranged from 2 to 27 
• one-off events, often advertised as open to the general public, the number of 
people involved ranged from 15 to 81 
• involvement that did not require a face-to-face meeting, for example using an 
electronic Delphi or survey, the numbers invited ranged from 29 to 340 people. 
When to involve people in a systematic review 
PPI at stages of the systematic review 
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A systematic review is a process involving a series of different stages. The Cochrane 
review ecosystem illustrates 11 key stages of a systematic review, from developing 
the question through to writing and publishing the review. A final, 12th, stage is 
disseminating the results of the review. People can be involved at any (or all) of 
these stages. There should always be a clear aim or objective associated with 
involvement of people within a systematic review. Often the aim will relate to 
decisions that need to be made within the systematic review process. Depending on 
the aim of involvement, people may be involved at 1 stage, at 2 or more stages, or 
they can be involved throughout the whole review.   
The Cochrane Involving People learning resource provides examples of systematic 
reviews that have involved people at the 12 different stages of a review process in 
order to meet a range of different aims. Table 2 provides some brief examples of PPI 
at different stages of systematic reviews, taken from the Involving People resource. 
Table 2 Examples of involvement of people at different stages of systematic 
reviews (from the Cochrane Involving People learning resource) 
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Clarify the review 
questions in a 
systematic review 
relating to complex 
mental health needs 
and services for 
children and 
adolescents in the 
UK 
Edwards et al. (2015) used 
2 different strategies. In 1 strategy, 
6 young people who had been 
mental health inpatients, were 
interviewed, individually. The aim 
was to identify topics for the review 
to focus on. In the second 
strategy, healthcare professionals, 
young people and charity 
representatives met face to face to 






Clarify methods for a 
Cochrane review 
update relating to 
physiotherapy for 
people who had 
experienced a 
stroke, in particular 
the categorisation of 
interventions 
Pollock et al. (2015) formed a 
stakeholder group of patients, 
carers and healthcare 
professionals. There were 
2 meetings that focused on 
clarifying methods of the planned 
review. The stakeholder group’s 
input generated a method for 
categorising interventions within 
the review. This method was used 
to structure the final review and 
also informed subgroup analyses. 





Agree the protocol 




children in school 
Liabo (2013) used a participatory 
approach to involve a group of 
young people throughout the 
review. At one of the meetings, 
participants were presented with a 
pre-prepared document with tick-
box options for different 
alternatives within the protocol. 
The options had been generated 
from the discussions at previous 
meetings that focused on the 
review question. The text included 
in the final protocol reflected the 
views that had been collected 




Rees et al. 
(2004) 
Advise on 
terminology for the 
search strategy, for 
a systematic review 
relating to HIV-
related sexual health 
for men 
Rees et al. (2004) involved a 
range of people in 3 meetings. In 
one of the meetings, the group 
specifically advised on terminology 
for the search strategy.  
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Aim of involvement What happened? 








Harris et al. (2016) established an 
advisory network of stakeholders. 
Communication with the advisory 
network occurred through a series 
of events, as well as less formal 
communication, including email. 
Harris et al. report that advisory 
network members helped to 
identify relevant unpublished 




Vale et al. 
(2012) 
Provide oversight to 
a Cochrane review 
of 
chemoradiotherapy 
for cervical cancer 
Vale et al. (2012) formed a group 
of ‘patient research partners’ who 
provided continuous oversight for 
the review. The group was actively 
involved in several review tasks, 
including tracing the address 
details of trial investigators for 
studies selected for inclusion. 
7. Collect data Bayliss et 
al. (2016) 
Co-produce a coding 
framework for the 
qualitative analysis 
in a qualitative 
systematic review 
focused on 
predictive testing for 
those at risk of 
developing a chronic 
inflammatory 
disease 
Bayliss et al. (2016) had a group of 
‘patient research partners’ who 
provided continuous oversight for 
the review. Three of the patient 
research partners volunteered to 
be involved in the qualitative 
analysis. They coded themes for a 
random selection of 3 papers and 
contributed to developing a co-
produced coding framework in 
collaboration with the researchers. 
This was done through email 
correspondence. Written training 
documents were developed to 
support the volunteers with this 
involvement. 
8. Assess risk 
of bias 
- - There is little evidence of 
involvement of stakeholders in the 
process of assessing risk of bias. 
Liabo (2013) reported that ‘none of 
the young people were interested 
in being involved in activities that 
required them to read the full 
studies’. As a result of this 
observation, these stakeholders 
were involved in ‘a general 
discussion about research quality 
rather than aiming for them to take 
an active part in reading the 
studies and assessing them for 
quality’. 
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comment on the 
qualitative themes 
generated for the 
qualitative synthesis 
The patient research partners 
involved in the review of Bayliss et 
al. (2016) attended a face-to-face 
meeting to which all stakeholders 
were invited. They read all the 
included papers before the 
meeting. Bayliss et al. reported 
that this session aimed to help 
researchers draw on the 
perspectives of the patient 
research partners when 







Gain consensus on 
the clinical 
implications arising 
from the review 
Pollock et al. (2014, 2015) held a 
stakeholder meeting at which the 
draft findings (results of meta-
analyses) were presented. 
Stakeholders were asked to 
discuss the clinical implications of 
these findings. Through 
discussion, the group agreed the 
wording of a series of statements 
relating to clinical implications, with 
anonymous voting used to confirm 
agreement with the statements. 
The agreed statements were 




et al. (2014) 
Get feedback on 
drafts of a 




research   
Colcannon et al. (2014) held 
2 face-to-face meetings with a 
group of stakeholders, who also 
participated by email and phone 
throughout the review process, 
including commenting on tables, 
figures and manuscript drafts. 
Colcannon et al. stated that 
‘stakeholders [at a second 
meeting] also helped us identify 
effective ways to communicate the 
findings in tables and figures for 
this manuscript. All stakeholders 
were invited to participate by email 
and phone throughout the 
research, including a review of the 
manuscript’’. 
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Aim of involvement What happened? 
12. Publishing 
the review and 
disseminating 
Hyde et al. 
(2017) 
Plan and contribute 
to disseminating the 
results of a review 






Hyde et al. (2017) held 
3 stakeholder meetings at different 
stages during the review. Group 
members were involved in 
‘planning how to share results’ and 
‘agreeing dissemination of the 
results’. Consequently, ‘results 
were targeted at practitioners, as 
[stakeholders] felt this was most 
important’. Hyde et al. reported 
that group members ‘participated 
in dissemination of the review 
findings’. They also reported that 
they ‘planned their own 
roles...including giving 
presentations and contributing the 
patient's perspective to 
discussions at conferences’. 
 
Top and tail approach 
Pollock et al. (2019) explored when systematic review authors had PPI in their 
reviews. They found that people were most commonly involved at the initial stages 
(stages 1 to 3: framing the question and planning the review) and the final stages 
(stages 10 to 12: interpretation, publication and dissemination of findings). It was 
less common for people to be involved during the middle stages (stages 4 to 9: 
conducting the review). Often people were involved at both the initial and final 
stages, but not in the middle – this has been termed a ‘top and tail’ approach 
(Pollock et al. 2019). A top and tail approach may involve the same group of people 
at the start and end of the review, or it may involve 2 different sets of people. 
For systematic reviews being planned and conducted as part of the development of 
a guideline, a top and tail approach could potentially fit efficiently within the guideline 
process. However, there is no evidence to support this as being the ‘best’ approach, 
and decisions about when to involve people should be made based on the pre-
determined aims of involvement for each individual systematic review. 
How to involve people in a systematic review 
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Approaches to involvement 
There is no evidence to show that any one way of involving people in a review is 
more or less impactful. Several different factors will influence the decision on the 
best approach for a specific systematic review. These factors may include the topic 
of the review, time available, resources available, and expertise of the review team. 
Two different approaches to involvement have been used for other systematic 
reviews: 
• Continuous involvement – people are involved ‘throughout’ the review process, 
perhaps as a member of the review author team or an advisory group. 
• One-time involvement – people are involved at a specific stage in a review in 
order to complete a specific task or address a specific aim. For example, a group 
of people might be involved in discussing and reaching consensus on the question 
for a review, or people might be involved in order to contribute to the writing a 
plain language summary.  
The aims of the PPI will help determine which approach might be best for a specific 
review. For example, if a key aim is to ensure that the outcomes included in the 
review reflect those that matter most to people affected by a particular health 
condition, then a one-time involvement approach may be more advantageous. This 
could enable a group of people to come together and reach consensus on the 
outcomes for the review. However, if the aim of involving people is to provide general 
oversight to the review process and ensure that all stages of the review process 
consider the views of patients and the public, then continuous involvement may be 
more advantageous. Some systematic reviews combine both approaches. For 
example, they may have PPI input on an advisory group throughout the review 
process, and then also plan 1 or more one-time events to get additional input into 
key stages of the review. 
Levels of involvement 
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Involvement of people in a systematic review can be considered as a continuum, 
from more involvement and control, to less involvement and control. Pollock at al. 
(2019) explored the different tasks and activities in which patients and the public 
were involved in a range of systematic reviews. Using an iterative process, they 
developed a new taxonomy relating to the actions, responsibilities and tasks of those 
involved, called the ‘ACTIVE continuum of involvement’. It describes people as 
leading, controlling, influencing, contributing or receiving (see table 3). 
Table 3 The ACTIVE continuum of involvement (from Pollock et al. 2019) 
Level of involvement Tasks 
Leading: Initiating the review; lead 
responsibility for carrying out and 
completion of review. 
Tasks will include authorship of a review, and may 
include any activities associated with review 
completion, including key decisions relating to the 
methods and execution of the review. 
Controlling: Working in 
partnership with researchers, with 
varying degrees of control or 
influence over the review process. 
Making decisions, controlling, or 
both, 1 or more aspects of the 
review process, in collaboration 
with or under the guidance of the 
review authors. 
Tasks may include defining outcomes of interest, 
inclusion criteria, key messages arising from review 
findings and writing a plain language summary.   
In completing tasks people have control over final 
decisions, such as application of inclusion criteria, 
categorisation of interventions, or 
recommendations for clinical practice. 
Influencing: Stating, commenting, 
advising, ranking, voting, 
prioritising, or reaching consensus. 
Providing data or information that 
should directly influence the review 
process, but without direct control 
over decisions or aspects of the 
review process.  
Tasks may include assisting with review tasks, 
such as hand searching, screening, data extraction 
and assessment of risk of bias, possibly in a co-
reviewer role. 
Tasks may include peer review, such as 
commenting on a protocol, systematic review or 
plain language summary. 
Contributing: Providing views, 
thoughts, feedback, opinions or 
experiences. Providing data or 
information that may indirectly 
influence the review process. 
People may be participants in a 
research study (for example, focus 
groups or interviews).  
Tasks may include sharing views or opinions, for 
example, within a focus group or interview. May 
include ranking, voting or prioritising as participants 
in a research study (for example, in a Delphi study).   
Receiving: Receiving information 
about the systematic review, or 
results of the review. 
Tasks may include attending events or reading or 
listening to information about the review. Although 
the results of a review may be discussed, these 
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Although the level of involvement of people in a systematic review can be seen as a 
continuum, there is no evidence of a hierarchical association between level, impact, 
benefit or success of involvement. Indeed, current evidence and opinion suggests 
that different levels and methods of involvement may be useful at different stages in 
a systematic review. What is important is to consider the level of PPI involvement, 
and their level of control or influence over the process. Decisions about the level of 
control that people will have at various stages in the review process should be stated 
in advance, ideally within the systematic review protocol. 
Format of involvement 
Format of involvement means the ways in which people interact and communicate, 
such as through face-to-face meetings, events or workshops, individual or group 
telephone or video-calls, or email and written communication. The format of PPI in a 
systematic review will depend on several factors. These factors include (but are not 
limited to) the aim of involvement, the people who are being involved, and the 
resources and time available for this. In an exploration of the format of involvement 
adopted in a range of systematic reviews, Pollock et al. (2018) found that direct face-
to-face interaction was the most common approach, and that this might comprise a 
small meeting, a larger workshop or public event, or a combination of these. In most 
cases, between 1 and 4 meetings or events were held throughout a review, although 
as many as 20 meetings had been held. Meetings varied in length from 1 hour to half 
a day. A small number of systematic reviews used electronic or remote methods to 
involve people. Most commonly, this was an electronic Delphi or survey method, 
usually involving 2 or 3 rounds of voting. 
Research methods and processes 
A range of different ways have been used when involving people in a systematic 
review. Often these methods and processes involve different ways of sharing 
thoughts and ideas, such as group discussions or written feedback. Several formal 
research methods have also been used when involving people. Adopting a formal 
research method or process can be useful when there is a clearly identified role, or 
aim, for the people involved. For example, the aim might be to reach consensus on 
the outcomes of relevance to the review, or to agree a way to synthesise the 
evidence so that it is accessible and understandable.  
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Formal research methods and processes that have been used when involving 
people in systematic reviews include: 
• Participatory research approaches: Include ‘action research’ and ‘participatory 
action research’ and are usually considered as ‘approaches’ to research, rather 
than methods. These approaches integrate PPI with qualitative research, with a 
joint process of knowledge production by researchers and patients or the public. 
Participatory research approaches have key tenets: a democratic impulse; 
iterative data collection and analysis, and simultaneous contributions to science, 
improvement and change.   
Box 1 Example of a participatory research approach 
For a realist review of community-based peer support, Harris et al. (2016) 
used participatory approaches to gain stakeholder involvement throughout 
the review. An advisory network was formed, comprising a range of 
different types of stakeholder. Recruitment to the advisory network took 
place throughout the review, and different individuals had varying levels of 
involvement, and at different stages. Some members contributed on 
multiple occasions and others on only a single occasion. A total of 
12 meetings were held throughout the review, providing approximately 
240 face-to-face contacts with around 120 stakeholders. In addition, there 
were also email discussions and opportunistic contact with researchers. 
 
• Consensus decision-making techniques: Include using techniques for voting (that 
is, to make decisions about the review) and ranking (for example, to prioritise 
domains, such as outcomes, within a review). It also includes the nominal group 
technique, which involves a structured discussion and rounds of voting to reach 
consensus on a specific problem or issue, and the Delphi method, which involves 
several rounds of questionnaires or surveys to achieve consensus. 
Box 2 Example of a consensus decision-making process 
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For an update of a Cochrane review relating to physiotherapy for people 
who had a stroke, Pollock et al. (2014, 2015) formed a stakeholder group 
comprising physiotherapists, stroke survivors and carers. During a series of 
3 meetings, stakeholders made several decisions relating to the review. 
Decisions were made using the nominal group technique. In each case, the 
stakeholder group members first discussed a topic or statement for an 
agreed amount of time. Then each stakeholder group member individually 
ranked their agreement with that topic or statement and noted their reasons 
for this. The ‘voting’ sheets were anonymous, but were then collected and 
counted in front of the group members in order to see whether or not there 
was consensus on a topic. Further rounds of discussion and voting took 
place when needed. 
 
• Group process: Often the process of involving people within a systematic review 
entails a group meeting, which may be called a meeting, workshop or conference. 
These meetings commonly involve discussion and debate, perhaps supplemented 
with formal methods such as consensus decision-making techniques. The content 
and processes within these group meetings are often poorly reported. However, 
evidence suggests that these meetings do often combine careful planning and use 
of techniques known to enhance the group process. The planning and approach 
to running group meetings provides a way of addressing many of the general 
issues identified as important to involvement, such as effective communication, 
clarity, expectations, respect and trust. 
Box 3 Resource on group process 
The Agency for Healthcare Research and Quality Practice’s Facilitator’s 
Guide to Running Effective Meetings provides a guide to key issues 
associated with planning and facilitating a group meeting.  
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• Qualitative research methods: These methods, such as interviews or focus 
groups, have been used to elicit views and opinions of patients and the public in 
relation to systematic reviews. The purpose has most commonly been to 
‘contextualise’ the findings of a systematic review to a particular population or 
area. These data have then been analysed using methods for analysis of 
qualitative data, such as thematic analysis (Bunn et al. 2015, Martin et al. 2015). 
In such cases, the involvement of people has occurred after completion of the 
systematic review. However, it could be argued that the involvement relates to the 
final stages of a systematic review process (such as dissemination and translation 
of evidence into practice). The level of involvement is one of ‘contribution’ and, in 
these examples, the people involved could arguably be described as ‘participants’ 
in research.  
Describing and reporting PPI within a systematic review 
It is good practice to report who, when and how people have been involved in a 
systematic review, and to reflect on the impact that this had on decision making and 
the final outputs of the review. This section presents 2 ways to aid reporting on PPI.  
The ACTIVE framework 
The ACTIVE framework (Pollock et al. 2019) provides a way of describing how and 
when people were involved in a systematic review. The framework, mentioned in the 
section on levels of involvement and shown in table 4, lists a series of framework 
constructs that should be reported and proposes categories for classifying how 
people were involved.  
Table 4 ACTIVE framework for describing involvement of people in a 
systematic review (adapted from Pollock et al. 2019) 
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• Patients, carers and their 
families  
• Patients, carers and their 
families, and other 
stakeholders 
• Other stakeholders only 
The ACTIVE framework provides a 
way of categorising who is 
involved, using 3 broad categories. 
A written description should also be 
provided, giving numbers of 
people, and key information (for 





• Open, fixed 
• Open, flexible 
• Closed, invitation 
• Closed, existing group 
• Closed, purposive 
sampling 
The ACTIVE framework provides a 
way of categorising the way in 
which people were recruited, using 
a series of categories based on the 
method of recruitment. 
A written description should also be 
provided, describing the targeted 
individuals or organisations, as well 





1. Develop question 
2. Plan methods 
3. Write and publish protocol 
4. Develop search 
5. Run search 
6. Select studies 
7. Collect data 
8. Assess risk of bias 
9. Analyse data 
10. Interpret findings 
11. Write and publish review 
12. Knowledge translation and 
impact 
EACH stage at which people are 
involved should be clearly stated. 
The aim of involvement at each 




Top and tail approach? If a top and tail approach is used 
this should be clearly stated, again 
stating the level of involvement at 






• One-time involvement 
• Continuous involvement 
• Combined involvement 
(that is, both one time and 
continuous) 
The categorisation of the approach 
to involvement gives a simple way 
of summarising what happened in 
terms of involving people in the 
review. Further details about what 
happened at each different stage at 
which there is involvement should 
also be provided, as outlined in the 
row on how people are involved, 
level of involvement. 
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For each stage at which people are 
involved, the level of involvement 
or control should be stated (see the 
ACTIVE Continuum in table 3 for 
definitions of levels and 
descriptions of tasks completed 
within each level). 
The level of involvement may vary 







• Direct interaction 
• No direct interaction 
The categorisation of the format of 
involvement gives a simple way of 
showing the format of the 
involvement. It is important to also 
provide a description of what 
happened during any interaction. 
Details of the number and length of 
the interactions should also be 
reported. Note whether any formal 
research methods and 
processes have been used, and if 
so, what these were. 
 
Several icons have also been developed, which may be useful for ‘labelling’ the PPI 
within systematic reviews. These icons are shown in table 5. 
 
Table 5 Icons relating to the ACTIVE framework for describing involvement of 
people in a systematic review 
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Who is involved?  Patients, carers and their families  
 
Who is involved?  Patients, carers and their families, and other 
stakeholders 
 
Who is involved?  Other stakeholders only  
How are people 
recruited? 
Open, fixed  
How are people 
recruited? 
Open, flexible  
How are people 
recruited? 
Closed, invitation  
How are people 
recruited? 
Closed, existing group  
How are people 
recruited? 
Closed, purposive sampling  
When are people 
involved? 
Top and tail approach? 
 










How are people 
involved? 
Approach? 
Combined involvement (that is, both one time and 
continuous) 
 
How are people 
involved? 
Approach? 
Direct interaction  




No direct interaction 
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The GRIPP2 (Guidance for Reporting Involvement of Patients and the Public 2) 
checklist (Staniszewska et al. 2017) is a guideline for reporting PPI in health and 
social care research. It is not specific to systematic reviews, and it aims to capture 
reflections relating to the impact of involvement, in addition to the methods, and 
other components. There is a long and short-form version. The long form includes 
34 items on aims, definitions, concepts and theory, methods, stages and nature of 
involvement, context, capture or measurement of impact, outcomes, economic 
assessment, and reflections. It is suitable for studies in which the main focus of the 
manuscript is PPI. The short form includes 5 items on aims, methods, results, 
outcomes, and critical perspective and is suitable for studies in which PPI is a 
secondary focus (for example, to briefly describe the PPI approach used within the 
manuscript describing the broader study). Although not specific to systematic 
reviews, the GRIPP2 checklist may provide a helpful guide for reporting the methods 
and impact of PPI and could be applied to a systematic review. 
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Resources for planning and conducting PPI in systematic 
reviews 
Cochrane’s Involving People  
A resource for systematic review editors and authors to support them in getting 
people involved in producing reviews. It is open access with a free Cochrane 
account. 
Stakeholder Engagement in Evidence Synthesis 
Open access resources related to engaging with stakeholders during planning, 
conducting and communicating evidence syntheses. 
Cochrane’s Consumer involvement training  
A collection of resources for those who want to involve consumers in producing 
systematic reviews. 
Webinars from the International Network for Patient and Public Involvement 
A series of open access recordings of webinars about engagement and involvement 
in an international context, including Stakeholder Involvement in Evidence Synthesis, 
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